Borer Denton & Associates, Inc. Novo Nordisk A S Transaction History
Borer Denton & Associates, Inc.
- $283 Billion
- Q1 2024
A detailed history of Borer Denton & Associates, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Borer Denton & Associates, Inc. holds 116,022 shares of NVO stock, worth $15.3 Million. This represents 5.27% of its overall portfolio holdings.
Number of Shares
116,022
Previous 116,222
0.17%
Holding current value
$15.3 Million
Previous $12 Billion
23.9%
% of portfolio
5.27%
Previous 4.6%
Shares
7 transactions
Others Institutions Holding NVO
# of Institutions
1,883Shares Held
310MCall Options Held
5.36MPut Options Held
4.95M-
Jennison Associates LLC21.1MShares$2.77 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.81 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.72 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.58 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.55 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $297B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...